Therapeutic monoclonal antibodies (mAbs) are a class of antibody drugs that are highly uniform and have pharmacological effects against a single epitope obtained through molecular biology. In the ...

Assessing the pharmacokinetics (PK) of antibody-drug conjugates (ADCs) in both preclinical and clinical settings is crucial for their development. Biotransformation processes can lead to the ...

Cancer treatment has entered a revolutionary phase with advancements in immunotherapy, a field that employs the immune system ...

Ray Lambert looks at the potential of humanized FcRn mice for evaluating the pharmacokinetics of mAbs ... human immunoglobulin gamma monoclonal antibodies (hIgG mAbs) are a most promising ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...